Skip to main content

Advertisement

Log in

Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objectives

Changes in lipid profiles, Lp(a) lipoprotein, and acute phase reactants are associated with early atherosclerosis in rheumatoid arthritis (RA). The associations of Lp(a) levels with atherosclerotic disorders, diabetes, RA, and renal diseases suggest that Lp(a) might be involved in autoimmune reactions.

Methods

Eighty-seven women with RA diagnosed according to American Rheumatism Association criteria (mean age 45.4±9.4 years) were recruited and 50 healthy women (mean age 44±10.7 years) included as a control group. Serum Lp(a), total cholesterol (TC), triglyceride (TG), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), and C-reactive protein levels were analyzed.

Results

In the RA and C groups, serum Lp(a) levels were 39.2±20.6 mg/dl and 14.8±9.7 mg/dl, respectively (P<0.001). The TC levels were 188.4±41.8 mg/dl and 185.3±19.3 mg/dl (P>0.05), TG levels were 124.5±50.1 mg/dl and 94.6±24.9 mg/dl (P<0.01), HDL-C levels were 40.0±7.4 mg/dl and 52.8±4.8 mg/dl (P<0.01), and LDL-C levels were 123.4±24.6 mg/dl and 113.3±21.1 mg/dl (P>0.05). While serum CRP levels showed a positive correlation with Lp(a), they correlated negatively with HDL-C levels (r=0.83 and P<0.0001, r=−0.49 and P<0.0001, respectively). It was meaningful that Lp(a) correlated negatively with serum HDL-C level (r=−0.36, P<0.001).

Conclusions

It is suggested that higher serum Lp(a), lower HDL-C, higher TG level, and a high ratio of TC/HDL-C might show high risk of atherosclerosis. Inflammation in RA may cause changes in HDL-C and Lp(a) metabolisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Isomaki HA, Mutru O, Koota K (1975) Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 4:205–208

    CAS  PubMed  Google Scholar 

  2. Abruzzo JL (1982) Rheumatoid arthritis and mortality. Arthritis Rheum 25:1020–1023

    CAS  PubMed  Google Scholar 

  3. Prior P, Symmons DPM, Scott DL, Brown R, Hawkins CF (1984) Causes of death in rheumatoid arthritis. Br J Rheumatol 23:92–99

    CAS  PubMed  Google Scholar 

  4. Mutro O, Laakso M, Isomaki H, Koota K (1985) Ten year mortality and causes of death in patients with rheumatoid arthritis. BMJ 290:1811–1813

    PubMed  Google Scholar 

  5. Wallberg-Jonsson S, Cederfelt M, Rantapää-Dahlqvist S (2000) Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year follow up study. J Rheumatol 27:71–75

    CAS  PubMed  Google Scholar 

  6. Scanu AM (1992) Lipoprotein (a): a genetic risk factor for premature coronary heart disease. JAMA 267:3326–3329

    Article  CAS  PubMed  Google Scholar 

  7. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62:707–714

    Article  CAS  PubMed  Google Scholar 

  8. Rantapää-Dahlqvist S, Wallberg-Jonsson S, Dahlen G (1991) Lipoprotein (a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 50:366–368

    PubMed  Google Scholar 

  9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    CAS  PubMed  Google Scholar 

  10. Assmann G, Schulte H, Cullen P (1997) New and classical risk factors-the Munster Heart study (PROCAM). Eur J Med Res 2:237–242

    CAS  PubMed  Google Scholar 

  11. Lakatos J, Harsagyi A (1988) Serum total HDL, LDL cholesterol and triglyceride levels in patients with rheumatoid arthritis. Clin Biochem 21:93–96

    CAS  PubMed  Google Scholar 

  12. Svensson K, Lithel H, Hallgren R, Selinus I, Vesby B (1987) Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides: I. Relativity to inflammatory activity. Arch Intern Med 147:1912–1916

    Article  PubMed  Google Scholar 

  13. Lorber M, Aviram M, Linn S, Scharf Y, Brook JG (1985) Hypocholesterolemia and abnormal high density lipoprotein in rheumatoid arthritis. Br J Rheumatol 24:250–255

    CAS  PubMed  Google Scholar 

  14. Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH, Song CH, Lee J (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26:1701–1704

    CAS  PubMed  Google Scholar 

  15. Asanuma Y, Kawai S, Aoshima H, Kaburaki J, Mizushima Y (1999) Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. Arthritis Rheum 42:443–447

    Article  CAS  PubMed  Google Scholar 

  16. Seriolo B, Accardo S, Cutolo M (1996) Lipoprotein (a) and other risk factors for thrombosis in rheumatoid arthritis. J Rheumatol 23:194–196

    CAS  Google Scholar 

  17. Seriolo B, Accardo S, Fasciolo D, Bertolini S, Cutolo M (1996) Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis. Clin Exp Rheumatol 14:593–599

    CAS  PubMed  Google Scholar 

  18. Seriolo B, Accardo S, Fasciolo D, Sulli A, Bertolini S, Cutolo M (1995) Lipoprotein (a) and anticardiolipin antibodies as risk factors for vascular disease in rheumatoid arthritis. Thromb Haemost 74:799–800

    CAS  PubMed  Google Scholar 

  19. Dahlen GH, Boman J, Birgander LS, Lindblom B (1995) Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 114:165–174

    Article  CAS  PubMed  Google Scholar 

  20. Dahlen GH (1994) Indications of an autoimmune component in Lp(a) associated disorders. Eur J Immunogenet 21:301–312

    CAS  PubMed  Google Scholar 

  21. Lee YH, Choi SJ, Ji JD, Seo HS, Song GG (2000) Lipoprotein (a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 19:324–325

    Article  CAS  PubMed  Google Scholar 

  22. Banks MJ, Kitas GD (1999) Lipoprotein (a) levels and atherosclerosis in rheumatoid arthritis: comment on the article by Asanuma et al. Arthritis Rheum 42:2491–2492

    Article  CAS  Google Scholar 

  23. Wallberg-Jonsson S, Uddhammar A, Dahlen G, Rantapää-Dahlqvist S (1995) Lipoprotein (a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica. Scand J Clin Lab Invest 55:309–315

    CAS  PubMed  Google Scholar 

  24. Dahlen GH (1994) Lp (a) lipoprotein in cardiovascular disease. Atherosclerosis 108:111–126

    CAS  PubMed  Google Scholar 

  25. Ehnholm C, Garoff H, Renkonen O, Simons K (1972) Protein and carbohydrate composition of Lp(a) lipoprotein from human plasma. Biochemistry 11:3229

    CAS  PubMed  Google Scholar 

  26. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115–126

    Article  CAS  PubMed  Google Scholar 

  27. Magaro M, Altomonte L, Zoli A, Mirone L, Ruffini MP (1991) Serum lipid pattern and apolipoproteins (A-I and B-100) in active rheumatoid arthritis. Z Rheumatol 50:168–170

    CAS  PubMed  Google Scholar 

  28. Gianturco SH, Bradley WA (1994) Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol 5:313–315

    CAS  PubMed  Google Scholar 

  29. Svensson K, Lithell H, Hallgren R, Selinus I, Vessby B (1987) Altered serum lipoproteins and enhanced lipoprotein elimination in patients with rheumatoid arthritis and other chronic inflammatory arthritides. I. Relationship to the inflammatory activity. Arch Intern Med 147:1912–1916

    Article  PubMed  Google Scholar 

  30. Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21:1876–1890

    CAS  PubMed  Google Scholar 

  31. Rossner S, Lofmark C (1977) Dyslipoproteinemia in patients with active chronic polyarthritis: a study on serum lipoproteins and triglycerides clearance (intravenous fat tolerance test). Atherosclerosis 28:41–52

    CAS  PubMed  Google Scholar 

  32. Lazarevic MB, Vitic J, Myones BL, Mladenovic V, Nanusevic N, Skosey JL, Swedler WI (1993) Antilipoprotein antibodies in rheumatoid arthritis. Semin Arthritis Rheum 22:385–391

    CAS  PubMed  Google Scholar 

  33. Wallberg-Jonsson S, Dahlen GH, Nilsson TK, Ranby M, Rantapää-Dahlqvist S (1993) Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis. Clin Rheumatol 12:318–324

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dursun Dursunoğlu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dursunoğlu, D., Evrengül, H., Polat, B. et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 25, 241–245 (2005). https://doi.org/10.1007/s00296-004-0438-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-004-0438-0

Keywords

Navigation